- Home
- ALT vs KOP Comparison
ALT vs KOP Comparison
Compare ALT & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- KOP
- Stock Information
- Founded
- ALT 1997
- KOP 1988
- Country
- ALT United States
- KOP United States
- Employees
- ALT N/A
- KOP N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- KOP Forest Products
- Sector
- ALT Health Care
- KOP Basic Materials
- Exchange
- ALT Nasdaq
- KOP Nasdaq
- Market Cap
- ALT 529.9M
- KOP 614.6M
- IPO Year
- ALT N/A
- KOP 2006
- Fundamental
- Price
- ALT $6.83
- KOP $32.37
- Analyst Decision
- ALT Strong Buy
- KOP Buy
- Analyst Count
- ALT 8
- KOP 1
- Target Price
- ALT $19.71
- KOP $64.00
- AVG Volume (30 Days)
- ALT 2.5M
- KOP 165.0K
- Earning Date
- ALT 11-12-2024
- KOP 02-26-2025
- Dividend Yield
- ALT N/A
- KOP 0.87%
- EPS Growth
- ALT N/A
- KOP N/A
- EPS
- ALT N/A
- KOP 3.52
- Revenue
- ALT $52,000.00
- KOP $2,128,300,000.00
- Revenue This Year
- ALT N/A
- KOP N/A
- Revenue Next Year
- ALT N/A
- KOP $1.54
- P/E Ratio
- ALT N/A
- KOP $9.03
- Revenue Growth
- ALT N/A
- KOP 0.22
- 52 Week Low
- ALT $5.28
- KOP $29.26
- 52 Week High
- ALT $14.84
- KOP $58.23
- Technical
- Relative Strength Index (RSI)
- ALT 41.57
- KOP 50.17
- Support Level
- ALT $6.19
- KOP $31.33
- Resistance Level
- ALT $7.83
- KOP $32.46
- Average True Range (ATR)
- ALT 0.39
- KOP 0.88
- MACD
- ALT -0.04
- KOP 0.31
- Stochastic Oscillator
- ALT 39.02
- KOP 83.83
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
About KOP Koppers Holdings Inc.
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.